Silencing or pharmacological inhibition of SIRT6 suppresses cSCC progression, promoting differentiation, blocking cell cycle progression, and reducing EMT markers, suggesting that SIRT6 supports tumor propagation [71]. The gene discussed is SIRT6; the disease is neoplasm.